Dr. med. Karin Huber

Facts

E-Mail: karin.huber[at]uksh.de

Affiliations: University Medical Center Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel

Curriculum vitae

Research Experience

since 07/2022	Clinician Scientist at the Clinic for Internal Medicine II, University Medical Center Schleswig-Holstein, Campus Kiel
since 04/2022	Resident at the Clinic for Internal Medicine II, University Medical Center Schleswig-Holstein, Campus Kiel, hematology and oncology
since 03/2018	Research Assistant (MD student); topic: “Aberrant signal transduction pathways in primary human leukemia stem cells”

Education/Training

01/2022	Issuance of the medical license
10/2014–12/2021	Medical School, Ruprecht-Karls-Universität Heidelberg

Fundings

06/2018 – 03/2020

MD scholarship, FAZIT-Stiftung

Project-related publications

P1, P3, P4, Z

Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial

Fransecky L, Fiedler W, Röllig C, Sauer T, Raffel S, Alsdorf W, Heberling L, Steer B, Huber K, Versteegen T, Spory L, Deckbar D, Reiser L, Bendig S, Bastian L, Bozzetti C, Beder T, Neumann M, Brüggemann M, Gökbuget N, Baldus C.

Ann Hematol

2026